ResearcherKumamoto UniversityActive in the last 2 years
Yasuhito Tanaka
Matched on ORCID iD 0000-0002-2473-6966; OpenAlex author ID A5009887722, A5139874470. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 26
2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper
Papers 4
- A Case of Pancreatic Cancer with High Tumor Mutation Burden Showing a Remarkable Response to Pembrolizumab. Co-author DOI 10.70352/scrj.cr.26-0273↗
- Serum Mac2-binding protein glycosylated isomer (M2BPGi) as a prognostic biomarker in pancreatic ductal adenocarcinoma: iCAFs-derived M2BPGi drives tumor invasi… Last author DOI 10.1007/s00535-024-02195-8↗
- Safety of biliary drainage with 6-mm metallic stent for preoperative obstructive jaundice in pancreatic cancer: PURPLE SIX STUDY. Co-author DOI 10.1111/jgh.16524↗
- Hepatitis B and C Virus Infection and Risk of Pancreatic Cancer: A Population-Based Cohort Study (JPHC Study Cohort II). Co-author DOI 10.1158/1055-9965.epi-15-1115↗
Closest collaborators
The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hiromitsu Hayashi · 2 shared papers, 2025–2026 · strength 0.51
- Paper A Case of Pancreatic Cancer with High Tumor Mutation Burden Showing a Remarkable Response to Pembrolizumab. DOI 10.70352/scrj.cr.26-0273↗
- Paper Serum Mac2-binding protein glycosylated isomer (M2BPGi) as a prognostic biomarker in pancreatic ductal adenocarcinoma: … DOI 10.1007/s00535-024-02195-8↗
- Kazuto Takata · 1 shared paper, 2026 · strength 0.30
- Yuki Kitano · 1 shared paper, 2026 · strength 0.30
- Rumi Itoyama · 1 shared paper, 2026 · strength 0.30
- Shigeki Nakagawa · 1 shared paper, 2026 · strength 0.30
- Hirohisa Okabe · 1 shared paper, 2026 · strength 0.30
- Masaaki Iwatsuki · 1 shared paper, 2026 · strength 0.30
- Naotaka Kugiyama · 1 shared paper, 2025 · strength 0.21
- Katsuya Nagaoka · 1 shared paper, 2025 · strength 0.21
- Hajime Yamazaki · 1 shared paper, 2025 · strength 0.21
- Takatsugu Ishimoto · 1 shared paper, 2025 · strength 0.21
- Yusuke Ishida · 1 shared paper, 2024 · strength 0.16
- Susumu Hijioka · 1 shared paper, 2024 · strength 0.16
- Daiki Yamashige · 1 shared paper, 2024 · strength 0.16
- Hidetoshi Kitamura · 1 shared paper, 2024 · strength 0.16
- Masanari Sekine · 1 shared paper, 2024 · strength 0.16
- Dai Inoue · 1 shared paper, 2024 · strength 0.16
- Reiko Yamada · 1 shared paper, 2024 · strength 0.16
- Takeshi Ogura · 1 shared paper, 2024 · strength 0.16
- Shota Harai · 1 shared paper, 2024 · strength 0.16
- Takuji Okusaka · 1 shared paper, 2024 · strength 0.16
- Shizuka Sasazuki · 1 shared paper, 2016 · strength 0.05
- Norie Sawada · 1 shared paper, 2016 · strength 0.05
- Manami Inoue · 1 shared paper, 2016 · strength 0.05
- Sarah Krull Abe · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.